Gambacorti-Passerini C, Brümmendorf TH, Kim D-W, Goh YT, Dyagil I, Pagnano K, Batai A, Turkina AG, Leip E, Purcell S, Leone J, Viqueira A, Cortes JE. Second-line bosutinib for chronic phase chronic myeloid leukemia after imatinib: final, 10-year results of a phase I/II study. haematol [Internet]. 2020Sep.10 [cited 2026Jun.19];. Available from: https://haematologica.org/article/view/14238